Literature DB >> 18754553

The future of cervical cancer prevention: human papillomavirus vaccines.

Louise Cadman1.   

Abstract

Human papillomavirus is recognised as the main cause of cervical cancer. Vaccines to protect against specific HPV types have been developed and a national HPV vaccination programme is due to begin in the UK in September 2008. Girls aged 12 to 13 years of age will be offered one of the vaccines, Cervarix, and it is hoped that it will offer them protection against over 70% of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754553

Source DB:  PubMed          Journal:  J Fam Health Care        ISSN: 1474-9114


  2 in total

1.  [Acceptance of the HPV vaccination by parents of 10-year old primary schoolgirls. One year later].

Authors:  Francesc Bobe Armant; Maria Eugenia Buil Arasanz; Amàlia Morro Grau; Griselda Trubat Muñoz
Journal:  Aten Primaria       Date:  2010-03-20       Impact factor: 1.137

2.  [Acceptance of the HPV vaccine by parents of 11-year old girls].

Authors:  Francesc Bobé Armant; Maria Eugenia Buil Arasanz; Amàlia Morro Grau; Griselda Trubat Muñoz
Journal:  Aten Primaria       Date:  2009-05-08       Impact factor: 1.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.